Back to Search
Start Over
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia.
- Source :
-
Leukemia [Leukemia] 2019 Jul; Vol. 33 (7), pp. 1805-1810. Date of Electronic Publication: 2019 Jan 24. - Publication Year :
- 2019
- Subjects :
- Animals
Carcinogenesis metabolism
Carcinogenesis pathology
Humans
Leukemia, Myelomonocytic, Juvenile metabolism
Leukemia, Myelomonocytic, Juvenile pathology
Mesenchymal Stem Cells metabolism
Mesenchymal Stem Cells pathology
Mice
Mice, Inbred BALB C
Neoplastic Stem Cells metabolism
Neoplastic Stem Cells pathology
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Antimetabolites, Antineoplastic pharmacology
Azacitidine pharmacology
Carcinogenesis drug effects
Leukemia, Myelomonocytic, Juvenile drug therapy
Mesenchymal Stem Cells drug effects
Neoplastic Stem Cells drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 33
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 30679798
- Full Text :
- https://doi.org/10.1038/s41375-018-0343-2